EU CRO TranScrip launches U.S. operation

TranScrip Partners is coming to America, as the U.K.-based CRO is opening its first stateside office to expand its global footprint.

The company has long offered its drug development services in the EU and expanded to Australia in September. Now, with a foothold in Philadelphia, TranScrip can pitch its end-to-end CRO platform to a larger client base, Managing Partner Flic Gabbay said.

"Establishing TranScrip's presence in the U.S. will allow us to better support our clients and their global drug development programs and will add to the depth and breadth of our expertise in drug development and commercialization," Gabbay said in a statement.

TranScrip bills itself as a one-stop option for outsourcers, handling drug development, medical affairs, pharmacovigilance, regulatory and medical writing for pre- and post-approval. The company has thus far partnered with more than 80 companies across four continents, and, with a U.S. base of operations, TranScrip expects more growth in the future.

- read the announcement

Suggested Articles

WuXi AppTec has cut the ribbon on its expanded Laboratory Testing Division in New Jersey as it looks to boost its integrated testing service portfolio.

St. Jude, Microsoft and DNAnexus have created a data-sharing and analysis platform to help accelerate pediatric cancer research.

The money will be used to expand its footprint in both China and the U.S., including a new R&D operation in Boston.